AAAAAA

   
Results: 1-9 |
Results: 9
ELISA QUANTITATION OF LP(A) CONCENTRATION DEMONSTRATES THAT LP(A) IS AN IMPORTANT RISK FACTOR IN CEREBROVASCULAR-DISEASE AND CARDIOVASCULAR-DISEASE
Authors: TADDEIPETERS WC JURGENS G WIKLUND O KOLTRINGER P PETEK W LINDEN T CHEN Q GREILBERGER J ULLSTROM C MACOMBER PF BUTMAN BT RANSOM JH
Citation: Wc. Taddeipeters et al., ELISA QUANTITATION OF LP(A) CONCENTRATION DEMONSTRATES THAT LP(A) IS AN IMPORTANT RISK FACTOR IN CEREBROVASCULAR-DISEASE AND CARDIOVASCULAR-DISEASE, The FASEB journal, 10(3), 1996, pp. 4313-4313
CHARACTERIZATION OF POLYCLONAL ANTIBODIES AGAINST HUMAN APOLIPOPROTEINS
Authors: MACOMBER PF TADDEIPETERS WC LYNCH RT RANSOM JH
Citation: Pf. Macomber et al., CHARACTERIZATION OF POLYCLONAL ANTIBODIES AGAINST HUMAN APOLIPOPROTEINS, The FASEB journal, 10(3), 1996, pp. 4324-4324
COMPARISON OF COMMERCIAL LP(A) IMMUNOASSAYS
Authors: TADDEIPETERS WC MACOMBER PF PLANK MC BUTMAN BT RANSOM JH SILBERMAN SR
Citation: Wc. Taddeipeters et al., COMPARISON OF COMMERCIAL LP(A) IMMUNOASSAYS, Clinical chemistry, 42(6), 1996, pp. 797-797
EPITOPE MAPPING OF MONOCLONAL-ANTIBODIES AGAINST HUMAN APOLIPOPROTEIN(A)
Authors: TADDEIPETERS WC MACOMBER PF JONES GR RANSOM JH BUTMAN BT BUTLER SM
Citation: Wc. Taddeipeters et al., EPITOPE MAPPING OF MONOCLONAL-ANTIBODIES AGAINST HUMAN APOLIPOPROTEIN(A), The FASEB journal, 9(4), 1995, pp. 766-766
LIPOPROTEIN(A) SERUM CONCENTRATION AND APOLIPOPROTEIN(A) PHENOTYPE CORRELATE WITH SEVERITY AND PRESENCE OF ISCHEMIC CEREBROVASCULAR-DISEASE
Authors: JURGENS G TADDEIPETERS WC KOLTRINGER P PETEK W CHEN Q GREILBERGER J MACOMBER PF BUTMAN BT STEAD AG RANSOM JH
Citation: G. Jurgens et al., LIPOPROTEIN(A) SERUM CONCENTRATION AND APOLIPOPROTEIN(A) PHENOTYPE CORRELATE WITH SEVERITY AND PRESENCE OF ISCHEMIC CEREBROVASCULAR-DISEASE, Stroke, 26(10), 1995, pp. 1841-1848
LIPOPROTEIN(A) LEVELS AND APOLIPOPROTEIN(A) ISOFORMS DIFFER AMONG ETHNIC POPULATIONS
Authors: TADDEIPETERS WC MACOMBER PF JURGENS G WIKLUND O KOLTRINGER P PETEK W LINDEN T CHEN Q ULSTROM C BUTMAN BT RANSOM JH
Citation: Wc. Taddeipeters et al., LIPOPROTEIN(A) LEVELS AND APOLIPOPROTEIN(A) ISOFORMS DIFFER AMONG ETHNIC POPULATIONS, The FASEB journal, 8(4), 1994, pp. 10000403-10000403
LIPOPROTEIN(A) CONCENTRATION IS A BETTER PREDICTOR FOR RISK OF CEREBROVASCULAR-DISEASE THAN CAROTID-ARTERY STENOSIS OR OTHER LIPOPROTEIN LEVELS
Authors: JURGENS G TADDEIPETERS WC KOLTRINGER P PETEK W QI C GREILBERGER J MACOMBER PF
Citation: G. Jurgens et al., LIPOPROTEIN(A) CONCENTRATION IS A BETTER PREDICTOR FOR RISK OF CEREBROVASCULAR-DISEASE THAN CAROTID-ARTERY STENOSIS OR OTHER LIPOPROTEIN LEVELS, Stroke, 25(1), 1994, pp. 247-247
QUANTIFICATION OF LIPOPROTEIN(A) PARTICLES CONTAINING VARIOUS APOLIPOPROTEIN(A) ISOFORMS BY A MONOCLONAL ANTI-APO(A) CAPTURE ANTIBODY AND APOLYCLONAL ANTI-APOLIPOPROTEIN-B DETECTION ANTIBODY SANDWICH ENZYME-IMMUNOASSAY
Authors: TADDEIPETERS WC BUTMAN BT JONES GR VENETTA TM MACOMBER PF RANSOM JH
Citation: Wc. Taddeipeters et al., QUANTIFICATION OF LIPOPROTEIN(A) PARTICLES CONTAINING VARIOUS APOLIPOPROTEIN(A) ISOFORMS BY A MONOCLONAL ANTI-APO(A) CAPTURE ANTIBODY AND APOLYCLONAL ANTI-APOLIPOPROTEIN-B DETECTION ANTIBODY SANDWICH ENZYME-IMMUNOASSAY, Clinical chemistry, 39(7), 1993, pp. 1382-1389
LIPOPROTEIN(A) CONCENTRATION AND APOLIPOPROTEIN(A) PHENOTYPE CORRELATE WITH SEVERITY OF CEREBROVASCULAR-DISEASE
Authors: JURGENS G TADDEIPETERS WC KOLTRINGER P PETEK W CHEN Q GREILBERGER J MACOMBER PF BUTMAN BT RANSOM JH
Citation: G. Jurgens et al., LIPOPROTEIN(A) CONCENTRATION AND APOLIPOPROTEIN(A) PHENOTYPE CORRELATE WITH SEVERITY OF CEREBROVASCULAR-DISEASE, Circulation, 88(4), 1993, pp. 169-169
Risultati: 1-9 |